In classic MG, antibodies against acetylcholine receptors (AChR) are the most common (~85%), followed by antibodies against muscle-specific kinase (MuSK) and low-density lipoprotein receptor-related protein 4 (LRP4) (both < 10%) [1,8]. This evidence concerns the gene LRP4 and myasthenia gravis.